- Home
- LESL vs IVVD Comparison
LESL vs IVVD Comparison
Compare LESL & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LESL
- IVVD
- Stock Information
- Founded
- LESL 1963
- IVVD 2020
- Country
- LESL United States
- IVVD United States
- Employees
- LESL N/A
- IVVD N/A
- Industry
- LESL Diversified Commercial Services
- IVVD Biotechnology: Pharmaceutical Preparations
- Sector
- LESL Miscellaneous
- IVVD Health Care
- Exchange
- LESL Nasdaq
- IVVD Nasdaq
- Market Cap
- LESL 66.9M
- IVVD 63.4M
- IPO Year
- LESL 2020
- IVVD 2021
- Fundamental
- Price
- LESL $0.28
- IVVD $1.15
- Analyst Decision
- LESL Hold
- IVVD Strong Buy
- Analyst Count
- LESL 9
- IVVD 4
- Target Price
- LESL $1.66
- IVVD $3.64
- AVG Volume (30 Days)
- LESL 1.9M
- IVVD 14.9M
- Earning Date
- LESL 08-06-2025
- IVVD 11-13-2025
- Dividend Yield
- LESL N/A
- IVVD N/A
- EPS Growth
- LESL N/A
- IVVD N/A
- EPS
- LESL N/A
- IVVD N/A
- Revenue
- LESL $1,250,568,000.00
- IVVD $46,210,000.00
- Revenue This Year
- LESL N/A
- IVVD $112.35
- Revenue Next Year
- LESL $0.64
- IVVD $272.14
- P/E Ratio
- LESL N/A
- IVVD N/A
- Revenue Growth
- LESL N/A
- IVVD 1941.08
- 52 Week Low
- LESL $0.27
- IVVD $0.35
- 52 Week High
- LESL $3.63
- IVVD $2.74
- Technical
- Relative Strength Index (RSI)
- LESL 34.91
- IVVD 56.13
- Support Level
- LESL $0.27
- IVVD $1.05
- Resistance Level
- LESL $0.34
- IVVD $1.45
- Average True Range (ATR)
- LESL 0.02
- IVVD 0.16
- MACD
- LESL -0.00
- IVVD 0.01
- Stochastic Oscillator
- LESL 12.50
- IVVD 47.37
About LESL Leslie's Inc.
Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products across chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company offers its products and services for Residential Pool, Residential Spa, Professional Pool, and Commercial Pool consumers. Geographically, it operates only in the United States.
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.